Gene · 4669
Papers3,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation between albuminuria and interstitial injury marker reductions associated with SGLT2 inhibitor treatment in diabetic patients with renal dysfunction. | Eur J Med Res | 2022 | 35933386 | PubTator, text mining | PubMed |
| [Lysosomal enzyme analysis of mucolipidosis type II α/β and type III α/β in two Chinese pedigrees]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2022 | 35929931 | PubTator, text mining | PubMed |
| The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function. | Physiol Rep | 2022 | 35924347 | PubTator, text mining | PubMed |
| Soil warming during winter period enhanced soil N and P availability and leaching in alpine grasslands: A transplant study. | PLoS One | 2022 | 35917373 | PubTator, text mining | PubMed |
| Structural basis for assembly and disassembly of the IGF/IGFBP/ALS ternary complex. | Nat Commun | 2022 | 35907924 | PubTator, text mining | PubMed |
| Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis. | Pathophysiology | 2022 | 35893595 | PubTator, text mining | PubMed |
| IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. | Pharmaceutics | 2022 | 35890374 | PubTator, text mining | PubMed |
| Phosphodiesterase-4 Inhibitor Roflumilast-Mediated Protective Effect in Sepsis-Induced Late-Phase Event of Acute Kidney Injury: A Narrative Review. | Pharmaceuticals (Basel) | 2022 | 35890197 | PubTator, text mining | PubMed |
| Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application. | J Pers Med | 2022 | 35887529 | PubTator, text mining | PubMed |
| DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers. | J Exp Clin Cancer Res | 2022 | 35883104 | PubTator, text mining | PubMed |
| Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape. | NPJ Genom Med | 2022 | 35882863 | PubTator, text mining | PubMed |
| Serum Adiponectin Level in Different Stages of Type 2 Diabetic Kidney Disease: A Meta-Analysis. | Comput Math Methods Med | 2022 | 35872926 | PubTator, text mining | PubMed |
| Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis. | Int J Nephrol | 2022 | 35866051 | PubTator, text mining | PubMed |
| Organizing structural principles of the IL-17 ligand-receptor axis. | Nature | 2022 | 35863378 | PubTator, text mining | PubMed |
| A Systematic Review of the (Un)known Host Immune Response Biomarkers for Predicting Recurrence of Urinary Tract Infection. | Front Med (Lausanne) | 2022 | 35860746 | PubTator, text mining | PubMed |
| Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health. | Biomark Insights | 2022 | 35859925 | PubTator, text mining | PubMed |
| The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study. | BMC Pediatr | 2022 | 35854249 | PubTator, text mining | PubMed |
| Adults with lysosomal storage diseases in the undiagnosed diseases network. | Mol Genet Genomic Med | 2022 | 35848209 | PubTator, text mining | PubMed |
| Associaton of Retinol Binding Protein 4 (RBP4) Levels With Hyperuricemia: A Cross-Sectional Study in a Chinese Population. | Front Endocrinol (Lausanne) | 2022 | 35846279 | PubTator, text mining | PubMed |
| Non-diabetic urine glucose in idiopathic membranous nephropathy. | Ren Fail | 2022 | 35820795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4669/papers?page=27